Company overview
Basic information
Company name
Eugenika, MB
Company code
304720863
Registered address
Kaunas, Europos pr. 30-8, LT-46326
Registration date
2017-11-24
Company age: 8 y. 11 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Other printing
Ownership form
Private without foreign capital
MB "Eugenika"
Company code: 304720863
Address: Kaunas, Europos pr. 30-8, LT-46326
Description
This description was generated by artificial intelligence.
Eugenika, MB (company code 304720863) is an operational private small partnership registered in 2017. The company belongs to the national private non-financial companies sector and is owned through private Lithuanian ownership, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Its governance is described as CEO only, and it is classified as a micro company. The registered address is in Kaunas, Europos pr. 30-8, in Kauno m. municipality, Kauno county.
The company’s main activity is EVRK C.18.12.00, Other printing. Financially, 2024 was the strongest recent year, with revenue of €75.0K and net profit of €11.5K. In 2025, revenue fell to €17.8K and the company posted a net loss of €14.0K, with a negative profit margin of 78.3%. Over the same year, equity declined to €423 while liabilities increased to €15.0K, indicating a weaker balance sheet position. Revenue was also lower than in 2023, when the company reported €19.0K in revenue and a net profit of €2.3K. Staff metrics are reported so far in 2026.
The company’s main activity is EVRK C.18.12.00, Other printing. Financially, 2024 was the strongest recent year, with revenue of €75.0K and net profit of €11.5K. In 2025, revenue fell to €17.8K and the company posted a net loss of €14.0K, with a negative profit margin of 78.3%. Over the same year, equity declined to €423 while liabilities increased to €15.0K, indicating a weaker balance sheet position. Revenue was also lower than in 2023, when the company reported €19.0K in revenue and a net profit of €2.3K. Staff metrics are reported so far in 2026.
Download a detailed company report
Make confident decisions with all the information about Eugenika, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.